Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Apr 23;25(9):4598.
doi: 10.3390/ijms25094598.

Genetic Landscape and Clinical Features of Hyperphenylalaninemia in North Ossetia-Alania: High Frequency of P281L and P211T Genetic Variants in the PAH Gene

Affiliations

Genetic Landscape and Clinical Features of Hyperphenylalaninemia in North Ossetia-Alania: High Frequency of P281L and P211T Genetic Variants in the PAH Gene

Inna S Tebieva et al. Int J Mol Sci. .

Abstract

This study, conducted in the Republic of North Ossetia-Alania (RNOA), aimed to explore the genetic landscape of hyperphenylalaninemia (HPA) and phenylketonuria (PKU) in the Ossetian population using data from newborn screening (NBS). Through comprehensive molecular genetic analysis of 29 patients with HPA from diverse ethnic backgrounds, two major genetic variants in the PAH gene, P281L and P211T, were identified, constituting 50% of all detected pathogenic alleles in Ossetian patients. Remarkably, these variants exhibited an exceptionally high frequency in the Ossetian population, surpassing global prevalence rates. This study unveiled a notable prevalence of mild forms of HPA (78%), underscoring the importance of genetic counseling for carriers of pathogenic variants in the PAH gene. Moreover, the findings emphasized the necessity for ongoing monitoring of patients with mild forms, as they may lack significant symptoms for diagnosis, potentially impacting offspring. Overall, this research offers valuable insights into the genetic landscape of HPA and PKU in the Ossetian population.

Keywords: Ossetian population; PAH gene; Republic of North Ossetia-Alania; frequent mutations; hyperphenylalaninemia; phenylketonuria.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflicts of interest.

References

    1. Van Spronsen F.J., Blau N., Harding C., Burlina A., Longo N., Bosch A.M. Phenylketonuria. Nat. Rev. Dis. Primers. 2021;7:36. doi: 10.1038/s41572-021-00267-0. - DOI - PMC - PubMed
    1. Fölling A. Über Ausscheidung von Phenylbrenztraubensäure in den Harn als Stoffwechselanomalie in Verbindung mit Imbezillität. Z. Physiol. Chem. 1934;227:169–176. doi: 10.1515/bchm2.1934.227.1-4.169. - DOI
    1. Voronin S.V., Zakharova E.Y., Baydakova G.V., Marakhonov A.V., Shchagina O.A., Ryzhkova O.P., Shilova N.V., Rumyantsev A.G., Shcherbina A.Y., Mukhina A.A., et al. Advanced neonatal screening for hereditary diseases in russia: First results and future prospects. Pediatria n. a. G.N. Speransky. 2024;103:16–29. doi: 10.24110/0031-403X-2024-103-1-16-29. (In Russian) - DOI
    1. Hillert A., Anikster Y., Belanger-Quintana A., Burlina A., Burton B.K., Carducci C., Chiesa A.E., Christodoulou J., Dordevic M., Desviat L.R., et al. The genetic landscape and epidemiology of phenylketonuria. Am. J. Hum. Genet. 2020;107:234–250. doi: 10.1016/j.ajhg.2020.06.006. - DOI - PMC - PubMed
    1. Shoraka H.R., Haghdoost A.A., Baneshi M.R., Bagherinezhad Z., Zolala F. Global prevalence of classic phenylketonuria based on neonatal screening program data: Systematic review and meta-analysis. Clin. Exp. Pediatr. 2020;63:34–43. doi: 10.3345/kjp.2019.00465. - DOI - PMC - PubMed

Substances